2025-08-01
To advance China's new industrialization agenda and accelerate breakthroughs in original and revolutionary biomanufacturing technologies, the Ministry of Industry and Information Technology of the PRC (MIIT) launched a national selection program for "Flagship Biomanufacturing Products." After provincial nominations and expert review, MIIT has officially announced the first batch of selected products.
Biomanufacturing, a core pillar of strategic emerging industries, is becoming a major engine for China's next stage of industrial development. The 36 products recognized this year span food, feed and additives, biopharmaceuticals, and other cutting-edge fields. Together, they highlight China's technological advances and establish national benchmarks that will significantly strengthen the industry's integrated capabilities—from R&D to production to commercialization.
Among the products selected is Fushine Biotech's filamentous fungal mycoprotein produced from Fusarium brachygibbosum. This recognition affirms both the product's technological value and Fushine Biotech's leadership in microbial protein innovation.
Fushine Biotech is a subsidiary of Fushine Pharmaceutical, leveraging the parent company's deep expertise and resources to strategically expand into microbial protein manufacturing.
Fushine Biotech is the first company in China to achieve ton-scale industrial production of microbial filamentous fungal mycoprotein, filling a domestic gap in large-scale manufacturing capacity.
02 Independent IP, Internationally Advanced
Fushine's core strain—Fusarium brachygibbosum—is protected by independent intellectual property rights and has been granted a national invention patent. Technology assessments organized by the China National Light Industry Council concluded that the strain and process have reached an internationally leading level.
03 Scalable Capacity, Strong Future Outlook
The company currently operates 1,200 tons/year of mature production capacity. Meanwhile, the first phase of its 200,000-ton/year microbial protein and resource-utilization project is under construction. Fushine Biotech is firmly positioned as a pioneer and frontrunner in China's microbial protein industry.
Being named in MIIT's first batch of "Flagship Biomanufacturing Products" marks a major milestone for Fushine Biotech. It signifies not only top-tier technological capability, but also the national expectation that Fushine will help lead market adoption and industry advancement in microbial protein.
Looking ahead, Fushine Biotech will continue to deepen its work in microbial protein, expand industrial capacity, and drive the wider application of efficient, sustainable protein solutions. The company is committed to contributing core strength to China's evolving biomanufacturing landscape and to advancing the industry toward higher global competitiveness.
